Skip to main content

Nektar Therapeutics 10-Q for FY2025 Q2

Nektar Therapeutics (NKTR)

10-Q 2025-08-08 For: 2025-06-30
View Original
Added on April 04, 2026

About this 10-Q

Nektar Therapeutics filed this 10-Q on August 8, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$11.18M
down 52.4% from $23.49M a year earlier
Net loss
$41.59M
compared with a net loss of $52.36M a year earlier
Diluted EPS
-$2.95
compared with -$3.76 a year earlier